Literature DB >> 17591648

Arachidonic acid and docosahexaenoic acid supplementation increases coronary flow velocity reserve in Japanese elderly individuals.

H Oe1, T Hozumi, E Murata, H Matsuura, K Negishi, Y Matsumura, S Iwata, K Ogawa, K Sugioka, Y Takemoto, K Shimada, M Yoshiyama, Y Ishikura, Y Kiso, J Yoshikawa.   

Abstract

BACKGROUND: Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are important components of phospholipids and cell membranes. There has, however, been no clinical report on the direct effects of ARA and DHA on coronary circulation.
OBJECTIVE: To evaluate the effects of ARA and DHA on coronary circulation using the measurement of coronary flow velocity reserve (CFVR) by transthoracic Doppler echocardiography (TTDE).
METHODS: A double-blind, placebo-matched study of 28 Japanese elderly individuals (19 men, mean age 65 years) conducted to compare the effects of polyunsaturated fatty acids (PUFA; ARA 240 mg/day, DHA 240 mg/day) and placebo on CFVR. Coronary flow velocity (CFV) of the left anterior descending coronary artery was measured at rest and during hyperaemia by TTDE to determine CFVR.
RESULTS: There were no significant differences in CFV at rest or during hyperaemia in CFVR at baseline in the two groups (PUFA versus placebo 17 (7 SD) versus 16 (6), 62 (20) versus 59 (12), and 3.85 (1.04) versus 3.98 (0.83) cm/s, respectively). After three months' supplementation, CFV during hyperaemia was significantly higher in the PUFA than in the placebo group (73 (19) versus 64 (12) cm/s, p<0.01) although no significant difference was found between the two groups in CFV at rest (17 (7) versus 16 (4) cm/s). CFVR thus significantly increased after PUFA consumption (3.85 (1.04) versus 4.46 (0.95), p = 0.0023).
CONCLUSION: Three months' supplementation of PUFA increased CFVR in Japanese elderly individuals, which suggests beneficial effects of PUFA on the coronary microcirculation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591648     DOI: 10.1136/hrt.2006.113159

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

1.  Differential effects of docoosahexaenoic and arachidonic acid on fatty acid composition and myosin heavy chain-related genes of slow- and fast-twitch skeletal muscle tissues.

Authors:  Michio Hashimoto; Takayuki Inoue; Masanori Katakura; Shahdat Hossain; Abdullah Al Mamun; Kentaro Matsuzaki; Hiroyuki Arai; Osamu Shido
Journal:  Mol Cell Biochem       Date:  2016-03-28       Impact factor: 3.396

2.  Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study.

Authors:  Saki Kakutani; Yoshiyuki Ishikura; Norifumi Tateishi; Chika Horikawa; Hisanori Tokuda; Masanori Kontani; Hiroshi Kawashima; Yutaka Sakakibara; Yoshinobu Kiso; Hiroshi Shibata; Ikuo Morita
Journal:  Lipids Health Dis       Date:  2011-12-22       Impact factor: 3.876

3.  Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model.

Authors:  Norifumi Tateishi; Yoshihisa Kaneda; Saki Kakutani; Hiroshi Kawashima; Hiroshi Shibata; Ikuo Morita
Journal:  Lipids Health Dis       Date:  2015-01-16       Impact factor: 3.876

4.  The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: A Mendelian randomization study.

Authors:  Ting Zhang; Jie V Zhao; C Mary Schooling
Journal:  EBioMedicine       Date:  2021-01-05       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.